RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Register / Egypt / DEA-EG-2023-0007
Egyptian Drug Authority · Egypt
DEA-EG-2023-0007
Tier 1 · Regulator-publishedUnclassifiedRecallStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
Periodic report no. (7) For 2023
Date issued
Jun 2023
Recorded by us
2026-09-06 19:45:29 UTC
Product
Anschlarin syrup 120 ml
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Manufacturer
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Batch numbers
210213
Expiry dates
Not published with the notice
Action type
Recall
Classification
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Not stated by the issuing authority
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Notice text
@egyptiandrugauthority www.edaegypt.gov.eg 15301 يونيو ٣٢٠٢ وذلــــــك لكـــون المســـتحضر صـــادر لـــه عـــدم مطابقة للتشـــغيلة الموضحة من قبل معامل هيئة الدواء المصرية. يتم ضبط وتحريز كافة العبوات من المستحضر الموضح أدناه: منشور Anschlarin syrup 120 ml 210213رقم التشغيلة Averroesالشركة المصنعة و صاحبة المستحضر
Original language: ar
Notice text in English
Circular, June 2023. All packs of the product described below are to be impounded and seized: Anschlarin syrup 120 ml, batch number 210213. The manufacturer and owner of the product is Averroes. A finding of non-conformity has been issued for the stated batch by the laboratories of the Egyptian Drug Authority.
Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
Status
Active
Superseded by
Not superseded. This is the current version.
Version
1

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
6216b9200766d8ed5429251ebacdaf1b936c9b31c0ffd1cb1a6085bb4814830a
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:36:42 UTC
Cite this record
Drug Eye Africa (2023). DEA-EG-2023-0007: Anschlarin syrup 120 ml — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2023/dea-eg-2023-0007

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.

DEA-EG-2023-0007 — Anschlarin syrup 120 ml · Drug Eye Africa